Stage | Considerations | Resource |
---|---|---|
Study design | Plan and justify the use of a proxy respondent, including specifying when a proxy is needed and allowed | |
 | Provide evidence of the psychometric properties of the proxy assessment tool | |
 | Specify the criteria for choosing who can act as a proxy (e.g., based on contact/closeness with the patient) | Montreal Accord [25]; ISOQOL user guide [11] |
 | For longitudinal studies, plan for the same proxy to respond across all time points | Neuro-QoL [48] |
 | Specify what domains a proxy can report on, and whether judgements can be made | PCORI minimum standards [16]; Montreal Accord [25]; MORECare [29]; FDA [3] |
Data Collection Methods | Describe how the proxy should respond (proxy- or patient-perspective) | ISOQOL user guide [11] |
 | Clear instructions for the proxy should be listed prior to the question | |
Analytic methods | Describe and justify whether and when patient-reported data might be replaced by proxy-reported data | EMA [2] |
 | Consider risk adjustment for proxy completion | |
 | Consider sensitivity analyses to assess the potential impact of proxy-reported data on interpretation of estimates | SPIRIT-PRO [27] |
Outcomes Interpretation | Consider whether the same proxy responded across all domains and time points | Neuro-QoL [48] |
 | Consider how proxy responses affect score interpretation and study results | |
Reporting recommendations | Report on considerations above, including: Summarize who completed the proxy reports, and what proxies reported on Describe specific instructions and perspective(s) used Detail any analytic methods for interpreting results from proxies | |
 | Differentiate patients and proxies in the results | |
 | Describe how proxy responses may have affected results |